Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 5 open reading frame 60 pseudogene (ENSG00000228259) is a **pseudogene**, meaning it is a segment of DNA that resembles a gene but is typically nonfunctional; it does not produce a functional protein product[2][4]. Pseudogenes arise through duplication or retrotransposition of protein-coding genes, after which they accumulate disabling mutations and lose their protein-coding ability[4]. While many pseudogenes are transcriptionally silent, a subset can be transcribed and may exert regulatory effects, for example by acting as competing endogenous RNAs or sources of regulatory peptides, but such functions are relatively rare and mostly unexplored[1][3][4]. Chromosome 5 open reading frame 60 pseudogene is **not considered a drug target**, nor is it a member of any receptor, enzyme, transporter, or other canonical molecular family used in therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 5 open reading frame 60 pseudogene.